リファキシミン

2020年8月21日 (金) 15:17時点におけるimported>Medicineによる版
(差分) ← 古い版 | 最新版 (差分) | 新しい版 → (差分)
rifaximin
  • 非吸収性抗生物質;過敏性腸症候群治療
  • Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is used in the treatment of traveler's diarrhea and hepatic encephalopathy, for which it received orphan drug status from the U.S. Food and Drug Administration in 1998.(wikipedia en)


参考

<click2in>http://en.wikipedia.org/wiki/Rifaximin#cite_ref-0</click2in>
<click2in>http://www.drugs.com/mtm/rifaximin.html</click2in>
<click2in>https://members.kaiserpermanente.org/kpweb/drugency/drugdetails.do?drugID=561118</click2in>
<click2in>http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM201081.pdf</click2in>